A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

BACKGROUND: The aim of this study is to demonstrate that capecitabine metronomic chemotherapy is non-inferior to capecitabine conventional chemotherapy as maintenance treatment, in patients who have responded to 16–18 weeks first-line chemotherapy in metastatic colorectal cancer (mCRC). METHODS: The...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: Shi, Min, Ma, Tao, Xi, Wenqi, Jiang, Jinling, Wu, Junwei, Zhou, Chenfei, Yang, Chen, Zhu, Zhenggang, Zhang, Jun
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059341/
https://ncbi.nlm.nih.gov/pubmed/32143730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-4194-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы